Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04528836
Title First-in-Human Study of the SHP2 Inhibitor BBP-398 in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Navire Pharma Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35249 United States Details
City of Hope Duarte California 91010 United States Details
Scripps MD Anderson Cancer Center La Jolla California 92037 United States Details
UC Irvine Health Orange California 92868 United States Details
UCLA Hematology/Oncology - Santa Monica Santa Monica California 90404 United States Details
Sarah Cannon Research Institute Denver Colorado 80218 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77096 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
NEXT Virginia Fairfax Virginia 22031 United States Details
MultiCare Institute for Research & Innovation Tacoma Washington 98405 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field